Cyclerion Therapeutics (CYCN) Notes Payables (2020 - 2021)
Cyclerion Therapeutics (CYCN) recorded quarterly Notes Payables of $3.5 million in Q3 2021, little changed quarter-over-quarter from $3.5 million in Q2 2021, and little changed on a YoY basis from $3.5 million in Q3 2020.
Cyclerion Therapeutics (CYCN) Notes Payables (2020 - 2021) Analysis & Trends
Cyclerion Therapeutics' Notes Payables history runs 2 years deep, the most recent figure standing at $3.5 million for Q3 2021.
- In Q3 2021, Notes Payables changed 0.0% year-over-year to $3.5 million; the TTM figure through Sep 2021 stood at $3.5 million (changed 0.0% YoY), while the FY2020 annual figure was $3.5 million, changed N/A from the prior year.
- Notes Payables was $3.5 million for Q3 2021 at Cyclerion Therapeutics, roughly flat from $3.5 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.5 million in Q2 2020 to a low of $3.5 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 3.51 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.51 Mn |
| Dec 31, 2020 | 3.51 Mn |
| Sep 30, 2020 | 3.51 Mn |
| Jun 30, 2020 | 3.51 Mn |